Advanced Search

Study Preview



Study Title and Description

Enteric-coated mycophenolate sodium in combination with full dose or reduced dose cyclosporine, basiliximab and corticosteroids in Australian de novo kidney transplant patients.



Key Questions Addressed
3 In adult renal transplants, how do immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity compare with each other and with full-dose CNI regimens for health outcomes? AND How does the type of induction agent (including when no induction is used) and the use of concurrent immunosuppressive agents affect outcomes of regimens that reduce or eliminate CNI exposure?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Enteric-coated mycophenolate sodium in combination with full dose or reduced dose cyclosporine, basiliximab and corticosteroids in Australian de novo kidney transplant patients.
Author Chadban S., Eris J., Russ G., Campbell S., Chapman J., Pussell B., Trevillian P., Ierino F., Thomson N., Hutchison B., Irish A., Woodcock C., Kurstjens N., Walker R.
Country Transplantation, Royal Prince Alfred Hospital, Sydney, Australia. steve.chadban@sswahs.nsw.gov.au
Year 2013
Numbers Pubmed ID: 23110508
1999 (internal)

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Comparative Effectiveness of Regimens


Results & Comparisons

No Results found.